Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01070563
Other study ID # IAAM 2010-1
Secondary ID
Status Completed
Phase N/A
First received February 12, 2010
Last updated June 30, 2011
Start date February 2009
Est. completion date June 2011

Study information

Verified date June 2011
Source Institut d'Anesthesiologie des Alpes Maritimes
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Observational

Clinical Trial Summary

In France the diagnosis of brain death relies on electroencephalography (EEG) or cerebral angiography. Concerning the latter a time of 6 hours is mandatory between the clinical diagnosis and the realization of the cerebral computed tomography (CT) angiography. Transcranial doppler (TCD) is not recommended in the french guidelines for the diagnosis of brain death. In other countries, some flow patterns allow to confirm the diagnosis of brain death. The hypothesis of our study is that TCD could shorten the time between the clinical diagnosis of brain death and the realization of the CT angiography.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- brain death patients

Exclusion Criteria:

- craniectomy

- post anoxia encephalopathy

- no TCD performed before the clinical diagnosis of brain death

- transtemporal approach impossible

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Transcranial doppler
A TCD is performed on all cerebral arteries (mean cerebral arteries, anterior cerebral arteries, basilar trunk, vertebral arteries and carotid arteries) until a flow pattern compatible with brain death is found

Locations

Country Name City State
France Centre Hospitalier Universitaire de Nice Nice

Sponsors (1)

Lead Sponsor Collaborator
Institut d'Anesthesiologie des Alpes Maritimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time between clinical diagnosis of brain death and realization of CT angiography the outcome is assessed when the CT angiography is performed No
Secondary Number of CT angiography required for the diagnosis of brain death the outcome is measured until the diagnosis of brain death is confirmed No